bio-regulatory-affairs-995x60 bio-regulatory-affairs-995x60

FEATURED ARTICLES

  • Federal Ruling Offers Some Regulatory Clarity For Biosimilars
    Federal Ruling Offers Some Regulatory Clarity For Biosimilars

    On July 21, 2015, the Federal Circuit reached a momentous decision in the case of Amgen vs. Sandoz. The significance of this ruling goes well beyond the rights of these particular manufacturers, as the decision marks the first step toward clarifying the regulatory path for U.S. biosimilar manufacturers.

More Featured Articles

WEBINAR

More Life Science Webinars